Jefferies 2016 London Healthcare Conference – November 16-17, 2016, London, UK

Bio-Europe 2016, 7th-9th November – Cologne, Germany

Our commercial director and general counsel, Dr. Hayley French and research director, Dr Lotta Jansson will be participating in the Bio-Europe partnering conference to be held November 7th – 9th in Cologne, Germany. They look forward to meeting with you to discuss potential partnerships.

FOCIS Annual Meeting 2016 – June 22-25th, Boston, USA

Prof. David Wraith, Apitope’s founder and CSO, will be presenting at the FOCIS annual meeting, to be held during June 22-25th being held in the Seaport and World Trade Centre Hotel in Boston, USA. David will be giving a presentation titled “Switching off unwanted immune responses: the mechanism of antigen-specific immunotherapy with T cell epitopes”.

For more details about the conference visit: http://www.focisnet.org/2013-03-07-14-01-50/2015-annual-meeting

BIO International Convention 2016, 6th-9th June, San Francisco, USA

Apitope’s commercial director and general counsel, Dr. Hayley French will be attending the BIO International Convention, to be held June 6th – 9th in the Moscone Convention Centre in San Francisco, USA. Hayley will be participating in the partnering sessions and is looking forward to meeting with you to discuss potential partnerships.

For more details about the convention, please visit BIO International’s website: http://convention.bio.org/

Apitope to Present at Bio€quity Europe in May 2016

Cardiff, UK and Hasselt, Belgium: 9 May 2016 − Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that Dr Keith Martin, CEO of Apitope, is scheduled to present at Bio€quity Europe on Tuesday, 10 May 2016 at 2.20 pm CET at the Scandic Hotel, Copenhagen, Denmark.

Now in its 17th year, Bio€quity Europe is a major industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects. Bio€quity Europe has showcased more than 700 leading European companies to thousands of investment and pharma business development professionals. Delegates from over 20 nations attended the event last year.